These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11249956)

  • 21. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
    Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
    Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of genes regulated by memantine and MK-801 in adult rat brain by cDNA microarray analysis.
    Marvanová M; Lakso M; Wong G
    Neuropsychopharmacology; 2004 Jun; 29(6):1070-9. PubMed ID: 14970830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.
    Grant KA; Colombo G; Grant J; Rogawski MA
    Neuropharmacology; 1996; 35(12):1709-19. PubMed ID: 9076750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists.
    Eriksson C; Zou LP; Ahlenius S; Winblad B; Schultzberg M
    Brain Res Mol Brain Res; 2000 Dec; 85(1-2):103-13. PubMed ID: 11146112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation by zinc of NMDA receptor-mediated synaptic responses in CA1 of rat hippocampal slices: mediation by Src family tyrosine kinases.
    Kim TY; Hwang JJ; Yun SH; Jung MW; Koh JY
    Synapse; 2002 Nov; 46(2):49-56. PubMed ID: 12211081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of in vivo [(3)H]MK-801 binding by NMDA receptor open channel blockers and GluN2B antagonists in rats and mice.
    Fernandes A; Wojcik T; Baireddy P; Pieschl R; Newton A; Tian Y; Hong Y; Bristow L; Li YW
    Eur J Pharmacol; 2015 Nov; 766():1-8. PubMed ID: 26325093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed preconditioning with NMDA receptor antagonists in a rat model of perinatal asphyxia.
    Makarewicz D; Sulejczak D; Duszczyk M; Małek M; Słomka M; Lazarewicz JW
    Folia Neuropathol; 2014; 52(3):270-84. PubMed ID: 25310738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum.
    Wang JQ; Daunais JB; McGinty JF
    Synapse; 1994 Dec; 18(4):343-53. PubMed ID: 7886627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
    Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiseizure efficacies of MK-801, phencyclidine, ketamine, and memantine are altered selectively by stress.
    Deutsch SI; Mastropaolo J; Riggs RL; Rosse RB
    Pharmacol Biochem Behav; 1997 Nov; 58(3):709-12. PubMed ID: 9329063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine.
    Narita M; Yoshizawa K; Nomura M; Aoki K; Suzuki T
    Eur J Pharmacol; 2001 Jun; 423(1):41-6. PubMed ID: 11438305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arcuate Src activation-induced phosphorylation of NR2B NMDA subunit contributes to inflammatory pain in rats.
    Xu L; Pan Y; Zhu Q; Gong S; Tao J; Xu GY; Jiang X
    J Neurophysiol; 2012 Dec; 108(11):3024-33. PubMed ID: 22993256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with NMDA receptor antagonists does not affect developmental changes in NMDA receptor properties in vivo.
    Van Lookeren Campagne M; Vermeulen JP; Boer GJ; Balázs R
    Neurochem Int; 1995; 27(4-5):355-66. PubMed ID: 8845736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia.
    Väisänen J; Ihalainen J; Tanila H; Castrén E
    Cell Mol Neurobiol; 2004 Dec; 24(6):769-80. PubMed ID: 15672679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR.
    Yoshikawa M; Kobayashi T; Oka T; Kawaguchi M; Hashimoto A
    Brain Res Mol Brain Res; 2004 Sep; 128(1):90-4. PubMed ID: 15337321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of NMDA-R antagonism on simultaneously acquired local field potentials and tissue oxygen levels in the brains of freely-moving rats.
    Kealy J; Commins S; Lowry JP
    Neuropharmacology; 2017 Apr; 116():343-350. PubMed ID: 28087359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.